Anemia in HIV/AIDS Patients on Antiretroviral Treatment at Ayder Specialized Hospital, Mekele, Ethiopia: A Case-Control Study.
Yemane BerhaneDiresibachew HaileTesfaye Tolessa DugulPublished in: Journal of blood medicine (2020)
We find that the prevalence of anemia was significantly higher among patients taking ZDV-containing regimen. But different risk factors for anemia had been identified among ZDV-containing regimen, showing that appropriate follow-up, nutritional supplementation, continuous evaluation of patients on cotrimoxazole intake can reduce the risks of anemia in both types of regimens.
Keyphrases
- end stage renal disease
- chronic kidney disease
- hiv aids
- ejection fraction
- newly diagnosed
- iron deficiency
- peritoneal dialysis
- risk factors
- palliative care
- human immunodeficiency virus
- emergency department
- patient reported outcomes
- antiretroviral therapy
- physical activity
- south africa
- body mass index
- patient reported
- weight gain
- smoking cessation
- combination therapy